AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Post Buyback Public Announcement
Post Buyback Public Announcement28-08-2023
28-08-2023
AARTI DRUGS LTD. - 524348 - Post-Buyback Public Announcement
Ingra Ventures Pvt. Ltd ("Manager to the Buyback") has submiited to BSE a copy of Post-Buyback Public Announcement for the attention of Equity Shareholders / Beneficial Owners of Equity Shares of Aarti Drugs Ltd ("Target Company").28-08-2023
AARTI DRUGS LTD. - 524348 - Letter of Offer
Ingra Ventures Pvt. Ltd ("Manager to the Buyback") has submiited to BSE a copy of Letter of Offer to the Equity Shareholders of Aarti Drugs Ltd ("Target Company").08-08-2023
AARTI DRUGS LTD. - 524348 - Corporate Action-Updates on Buy back
Letter of Offer for Buyback of Equity Shares07-08-2023
AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate04-08-2023
AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of duplicate share certificate02-08-2023
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Q1 FY24 Earning Conference Call28-07-2023
AARTI DRUGS LTD. - 524348 - Corporate Action-Updates on Buy back
Public Announcement of Buy-back25-07-2023
AARTI DRUGS LTD. - 524348 - Certified Copy Of The Resolution Passed By The Board Of Directors Of The Company At Its Meeting Held On July 21, 2023, Approving The Proposal To Buyback
Certified copy of the resolution passed by the Board of Directors of the Company at its meeting held on July 21, 2023, approving the proposal of Buyback25-07-2023
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Recording of earning call on the financial results for the quarter ended June 30, 202324-07-2023